- Home
- CHI vs INMD Comparison
CHI vs INMD Comparison
Compare CHI & INMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CHI | INMD |
|---|---|---|
| Founded | 2002 | 2008 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Investment Managers | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 930.8M | 842.0M |
| IPO Year | 2002 | 2018 |
Fundamental Metrics
Financial Performance| Metric | CHI | INMD |
|---|---|---|
| Price | $12.48 | $13.81 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $17.33 |
| AVG Volume (30 Days) | 172.7K | ★ 685.0K |
| Earning Date | 01-01-0001 | 05-06-2026 |
| Dividend Yield | ★ 9.90% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $1.74 |
| Revenue Next Year | N/A | $3.26 |
| P/E Ratio | ★ N/A | $10.11 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.00 | $12.72 |
| 52 Week High | $12.70 | $16.74 |
Technical Indicators
Market Signals| Indicator | CHI | INMD |
|---|---|---|
| Relative Strength Index (RSI) | 68.04 | 44.27 |
| Support Level | $10.91 | $13.32 |
| Resistance Level | N/A | $13.87 |
| Average True Range (ATR) | 0.19 | 0.30 |
| MACD | 0.02 | -0.08 |
| Stochastic Oscillator | 76.25 | 42.06 |
Price Performance
Historical ComparisonAbout CHI Calamos Convertible Opportunities and Income Fund
CALAMOS CONVERTIBLE OPPORTUNITIES & INCOME FUND operates as a closed-end management investment company. Its investment objective is to provide total return through a combination of capital appreciation and current income. The Fund invests in convertible securities and high-yield securities.
About INMD InMode Ltd.
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF, and Morpheus8, among others. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia, Israel, and other regions.